SEC Form 4 · accession 0001445064-15-000124
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ian J Watkins
Officer — Sr. VP & Chief HR Officer
Period of report
Aug 26, 2015
Accepted (ET)
Aug 27, 2015 · 7:02 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Aug 26, 2015 | P | 610 | $82.4361 | A | 12,988 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 162 shares acquired under the Mallinckrodt employee stock purchase plan since January 2, 2015.